Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients-Reference-Cited by-同舟云学术

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients

Published:2022-02-08 Issue:6 Volume:26 Page:571-580
ISSN:1342-1751
Container-title:Clinical and Experimental Nephrology
language:en
Short-container-title:Clin Exp Nephrol

Author:

Toda Masataro,Yoshifuji Ayumi^ORCID,Kikuchi Kan,Koinuma Masayoshi,Komatsu Motoaki,Fujii Kentaro,Kato Ai,Kikuchi Takahide,Nakazawa Atsushi,Ryuzaki Munekazu

Publisher

Springer Science and Business Media LLC

Subject

Physiology (medical),Nephrology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10157-022-02188-y.pdf

Reference20 articles.

1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med. 2020;383(27):2603–15. https://doi.org/10.1056/NEJMoa2034577.

2. Frantzen L, Cavaille G, Thibeaut S, El-Haik Y. Efficacy of the BNT162b2 mRNA covid-19 vaccine in a hemodialysis cohort. Nephrol Dial Transplant. 2021. https://doi.org/10.1093/ndt/gfab165.

3. Yen CC, Lin SY, Chen SC, Chiu YW, Chang JM, Hwang SJ. COVID-19 vaccines in patients with maintenance hemodialysis. J Pers Med. 2021. https://doi.org/10.3390/jpm11080789.

4. Garcia-Beltran WF, Lam EC, Astudillo MG, Yang D, Miller TE, Feldman J, et al. COVID-19-neutralizing antibodies predict disease severity and survival. Cell. 2021;184(2):476-88.e11. https://doi.org/10.1016/j.cell.2020.12.015.

5. Bergwerk M, Gonen T, Lustig Y, Amit S, Lipsitch M, Cohen C, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021. https://doi.org/10.1056/NEJMoa2109072.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between Tobacco Smoking and Self-Reported SARS-CoV-2/COVID-19 Infections, Disease Severity, and Duration in the German Population;SUCHT;2024-04

2. Cellular and humoral immune responses to COVID-19 booster vaccination in Japanese dialysis patients;Clinical and Experimental Nephrology;2024-03-08

3. Comparison of Humoral Response between Third and Fourth Doses of COVID-19 Vaccine in Hemodialysis Patients;Vaccines;2023-10-12

4. Robust antibody response after the third mRNA coronavirus vaccination in Japanese hemodialysis patients;Renal Replacement Therapy;2023-07-31

5. Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis;Vaccines;2023-07-06